Skip to content
October 12, 2026
  • Home
  • About Us
  • Contact Us
  • Cookies
  • Disclaimer
  • DMCA
  • Privacy Policy
  • TOS
Kanker Payudara

Kanker Payudara

Primary Menu
  • Home
  • About Us
  • Contact Us
  • Cookies
  • Disclaimer
  • DMCA
  • Privacy Policy
  • TOS
Watch
  • Home
  • Patient Advocacy and Support
  • Navigating the "New Normal": Breast Cancer Canada Announces Comprehensive Survivorship Webinar Series for October 2026
  • Patient Advocacy and Support

Navigating the "New Normal": Breast Cancer Canada Announces Comprehensive Survivorship Webinar Series for October 2026

Lina Irawan October 12, 2026 7 minutes read
navigating-the-new-normal-breast-cancer-canada-announces-comprehensive-survivorship-webinar-series-for-october-2026-1

TORONTO, ON — As medical advancements continue to improve survival rates for breast cancer, the focus of the oncology community is increasingly shifting toward what happens after the final round of chemotherapy or the last session of radiation. For many, the conclusion of active treatment marks the beginning of a complex and often daunting transition. To address this critical "gap" in care, Breast Cancer Canada has unveiled a specialized webinar series for October 2026, designed to provide survivors with the evidence-based tools necessary to navigate the physical, nutritional, and emotional landscapes of life after cancer.

The series, titled "Life Beyond Treatment," features a curated panel of experts, including registered dietitians, advocates, and survivors, who will tackle the lingering effects of the disease that are often overlooked in the clinical setting.

Main Facts: Addressing the Post-Treatment Gap

The transition from "patient" to "survivor" is frequently characterized by a sudden loss of the intensive support system provided by medical teams during active treatment. This period, often called the "New Normal," involves managing long-term side effects of medication, physical changes to the body, and the psychological weight of potential recurrence.

Breast Cancer Canada’s October 2026 initiative is structured as a three-part educational journey. The sessions aim to replace the misinformation often found online with clinical expertise and lived experience. The primary objectives of the series include:

  • Nutritional Optimization: Providing science-backed dietary strategies to manage weight and bone health.
  • Physical Rehabilitation: Addressing the long-term impacts of surgery, such as lymphedema and scar tissue.
  • Emotional Resilience: Offering frameworks for psychological recovery and the reintegration into professional and social life.

By focusing on these three pillars, the organization seeks to empower survivors to take agency over their health in the years following their diagnosis.

Chronology of the Series: A Month of Recovery

The webinar series is scheduled to take place every Thursday throughout the middle of October, with each session focusing on a specific dimension of survivorship.

October 8, 2026: Evidence-Based Nutrition with Jean LaMantia

The series kicks off with Jean LaMantia, a Registered Dietitian and cancer survivor herself. LaMantia’s session focuses on the intersection of nutrition and recovery. This session is particularly critical given the high volume of "wellness" misinformation targeting cancer patients on social media. LaMantia will guide participants through protein requirements for muscle maintenance, weight management strategies, and the specific dietary needs of those undergoing endocrine (hormone) therapy.

October 15, 2026: Physical Effects and Body Image with Voula Pantelis

The second week shifts focus to the physical body. Led by Voula Pantelis, a Breast Cancer Advocate and General Manager of AMOENA Canada, this session addresses the tangible changes survivors face. From the management of surgical scars and lymphedema to the nuances of selecting compression garments and returning to physical activity, Pantelis will provide a roadmap for physical comfort and the restoration of body image.

October 22, 2026: Emotional Transitions and the "Root to Rise" Framework

The final session, hosted by Jacqueline Beatty, founder of Rising Lotus, explores the psychological landscape of survivorship. Beatty will introduce her "Root to Rise" framework, which focuses on emotional regulation and the re-establishment of personal values. This session is designed to help survivors navigate the return to work and the shift in identity that often follows a life-threatening illness.

Supporting Data: The Growing Need for Survivorship Care

The necessity of this series is underscored by current oncological data. According to the Canadian Cancer Society, breast cancer has an 89% five-year net survival rate. However, this high survival rate has created a massive population of "long-term survivors" who deal with chronic side effects.

The Impact of Endocrine Therapy

Approximately 70-80% of breast cancers are estrogen-receptor-positive, meaning many survivors remain on endocrine therapy (such as Tamoxifen or Aromatase Inhibitors) for five to ten years after active treatment. Data shows that these medications, while life-saving, can lead to:

  • Bone Density Loss: A significant increase in the risk of osteoporosis and fractures.
  • Weight Gain: Metabolic shifts that can impact cardiovascular health and self-esteem.
  • Joint Pain: A leading cause of patients discontinuing their medication prematurely.

Lymphedema and Physical Morbidity

Research suggests that between 20% and 30% of breast cancer survivors will develop lymphedema—a chronic swelling of the arm or torso—following lymph node removal or radiation. Early intervention and proper compression, topics covered in the October 15th webinar, are statistically proven to reduce the severity of this condition.

The Psychological Burden

Studies in the Journal of Clinical Oncology indicate that nearly 40% of breast cancer survivors report significant psychological distress, including anxiety regarding recurrence and "chemobrain" (cognitive impairment). The "Root to Rise" framework being presented on October 22nd directly addresses these statistics by providing tools for emotional regulation.

Official Responses: Insights from the Experts

The speakers involved in the series emphasize that survivorship is not a passive state but an active process of rebuilding.

Jean LaMantia, RD, highlights the danger of restrictive dieting fueled by fear. "Nutrition advice can be overwhelming," LaMantia notes. "My goal is to offer practical approaches to building balanced meals without unnecessary restrictions. We want to nourish the body to prevent recurrence, not starve it out of fear."

Voula Pantelis of AMOENA Canada stresses the importance of addressing the physical "reminders" of cancer. "Treatment may end, but physical changes can continue. Whether it’s scar management or travel considerations for those with lymphedema, we need to talk about the practicalities of living in a post-surgical body."

Jacqueline Beatty emphasizes the internal shift required for long-term health. "The transition beyond treatment can bring complicated emotions. Uncertainty and questions about identity are normal. Through the ‘Root to Rise’ framework, we focus on reconnecting with personal values and setting boundaries as survivors re-enter their everyday routines and workplaces."

Implications: A Shift Toward Holistic Oncology

The Breast Cancer Canada webinar series represents a broader shift in the medical landscape toward "Holistic Oncology." For decades, the metric of success in cancer care was purely survival. However, as the survivor population grows, the metric is evolving to include Quality of Life (QoL).

1. Bridging the Communication Gap

One of the primary implications of this series is the empowerment of the patient. By providing evidence-based information, survivors are better equipped to advocate for themselves during follow-up appointments with their primary care physicians, who may not always be specialized in oncology-related side effects.

2. Reducing Recurrence Risk through Lifestyle

While no diet or exercise regimen can guarantee cancer will not return, the data-driven approaches discussed by LaMantia and Pantelis—such as maintaining a healthy BMI and regular physical activity—are clinically recognized as factors that can lower the risk of recurrence and improve overall metabolic health.

3. Economic and Workplace Reintegration

The focus on the transition back to work in the final session has significant economic implications. Many survivors face "financial toxicity" due to the costs of treatment and time away from work. Providing emotional and cognitive strategies for returning to the workforce helps mitigate the long-term financial impact of the disease.

4. Community and Peer Support

Beyond the information provided, these webinars serve as a virtual community. The "fear of recurrence" is a lonely experience; seeing experts and fellow survivors discuss these topics openly reduces the stigma and isolation often felt during the post-treatment phase.

Conclusion

The "Life Beyond Treatment" series by Breast Cancer Canada is more than just a set of presentations; it is a vital intervention for a growing demographic of Canadians. By addressing the protein needs of a healing body, the complexities of a post-surgical physique, and the emotional architecture of a "re-rooted" life, the organization is ensuring that "surviving" is only the beginning. As Jean LaMantia, Voula Pantelis, and Jacqueline Beatty prepare to share their expertise this October, the message is clear: recovery is a multifaceted journey, and no survivor should have to navigate the path alone.


For those interested in attending, registration links for the "Living Well" and "Moving Emotions Forward" sessions are available through the Breast Cancer Canada portal. Presentation slides for the nutrition session will be made available for download to ensure the evidence-based guidance remains accessible to all.

About the Author

Lina Irawan

Author

View All Posts

Post navigation

Previous: A Beacon of Resilience: WHO Director-General Strengthens Global Health Ties During Landmark Visit to Jordan
Next: FDA Approves Triple-Combination Maintenance Therapy for HER2-Positive Metastatic Breast Cancer: A New Standard of Care

Related Stories

navigating-the-intersection-of-glp-1-medications-and-breast-cancer-a-comprehensive-analysis-1
  • Patient Advocacy and Support

Navigating the Intersection of GLP-1 Medications and Breast Cancer: A Comprehensive Analysis

Lina Hope October 12, 2026
global-skyline-to-glow-in-teal-green-and-pink-lightupmbc-2026-sets-record-for-metastatic-breast-cancer-advocacy
  • Patient Advocacy and Support

Global Skyline to Glow in Teal, Green, and Pink: #LightUpMBC 2026 Sets Record for Metastatic Breast Cancer Advocacy

Nana Wu October 12, 2026
Set iv fluid intravenous drop saline drip hospital room,Medical Concept,treatment emergency and injection drug infusion care chemotherapy, concept.blue light background,selective focus stock photo
  • Patient Advocacy and Support

FDA Approves Triple-Combination Maintenance Therapy for HER2-Positive Metastatic Breast Cancer: A New Standard of Care

Reynand Wu October 12, 2026

Recent Posts

  • Groundbreaking Oklahoma Research Unveils How Aggressive Breast Cancer Hijacks Immune System to Fuel Growth
  • AstraZeneca Pursues Hypophosphatasia Treatment Despite Clinical Trial Setback
  • Navigating the Intersection of GLP-1 Medications and Breast Cancer: A Comprehensive Analysis
  • Global Skyline to Glow in Teal, Green, and Pink: #LightUpMBC 2026 Sets Record for Metastatic Breast Cancer Advocacy
  • FDA Approves Triple-Combination Maintenance Therapy for HER2-Positive Metastatic Breast Cancer: A New Standard of Care

Recent Comments

No comments to show.

Archives

  • October 2026
  • September 2026
  • August 2026
  • July 2026
  • June 2026
  • May 2026
  • September 2025
  • August 2025
  • July 2025

Categories

  • Breast Cancer Legislation and Policy
  • Breast Cancer Prevention and Lifestyle
  • Breast Cancer Surgery and Reconstruction
  • Chemotherapy and Targeted Therapy
  • Clinical Oncology Education
  • Clinical Radiology and Imaging
  • Genomics and Precision Medicine
  • Global Breast Cancer Awareness
  • Hormone Therapy and Endocrinology
  • Integrative Oncology and Holistic Care
  • Medical Research and Clinical Trials
  • Metastatic Breast Cancer Research
  • Patient Advocacy and Support
  • Psychosocial Support and Mental Health
  • Radiation Oncology
  • Survivorship and Post-Treatment
  • Treatment Innovations

You may have missed

groundbreaking-oklahoma-research-unveils-how-aggressive-breast-cancer-hijacks-immune-system-to-fuel-growth-2
  • Medical Research and Clinical Trials

Groundbreaking Oklahoma Research Unveils How Aggressive Breast Cancer Hijacks Immune System to Fuel Growth

Nana Muazin October 12, 2026
astrazeneca-pursues-hypophosphatasia-treatment-despite-clinical-trial-setback
  • Medical Research and Clinical Trials

AstraZeneca Pursues Hypophosphatasia Treatment Despite Clinical Trial Setback

Muslim October 12, 2026
navigating-the-intersection-of-glp-1-medications-and-breast-cancer-a-comprehensive-analysis-1
  • Patient Advocacy and Support

Navigating the Intersection of GLP-1 Medications and Breast Cancer: A Comprehensive Analysis

Lina Hope October 12, 2026
global-skyline-to-glow-in-teal-green-and-pink-lightupmbc-2026-sets-record-for-metastatic-breast-cancer-advocacy
  • Patient Advocacy and Support

Global Skyline to Glow in Teal, Green, and Pink: #LightUpMBC 2026 Sets Record for Metastatic Breast Cancer Advocacy

Nana Wu October 12, 2026
  • Home
  • About Us
  • Contact Us
  • Cookies
  • Disclaimer
  • DMCA
  • Privacy Policy
  • TOS
  • Home
  • About Us
  • Contact Us
  • Cookies
  • Disclaimer
  • DMCA
  • Privacy Policy
  • TOS
Copyright © All rights reserved. | MoreNews by AF themes.